Hand transplantation in the United States: A review of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Database

Hand transplantation is the most common application of vascularized composite allotransplantation (VCA). Since July 3, 2014, VCAs were added to the definition of organs covered by federal regulation (the Organ Procurement and Transplantation Network (OPTN) Final Rule) and legislation (the National O...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of transplantation Vol. 20; no. 5; pp. 1417 - 1423
Main Authors Hein, Rachel E., Ruch, David S., Klifto, Christopher S., Leversedge, Fraser J., Mithani, Suhail K., Pidgeon, Tyler S., Richard, Marc J., Cendales, Linda C.
Format Journal Article
LanguageEnglish
Published United States Elsevier Limited 01.05.2020
Subjects
Online AccessGet full text
ISSN1600-6135
1600-6143
1600-6143
DOI10.1111/ajt.15704

Cover

More Information
Summary:Hand transplantation is the most common application of vascularized composite allotransplantation (VCA). Since July 3, 2014, VCAs were added to the definition of organs covered by federal regulation (the Organ Procurement and Transplantation Network (OPTN) Final Rule) and legislation (the National Organ Transplant Act). As such, VCA is subject to requirements including data submission. We performed an analysis of recipients reported to the OPTN to have received hand transplantation between 1999 and 2018. Forty‐three patients were identified as having been listed for upper extremity transplantation in the United States. Of these, 22 received transplantation prior to July 3, 2014 and 10 from then to December 31, 2018. Of patients transplanted after 2014, posttransplant functional scores included a decrease in Disabilities of the Arm, Shoulder and Hand questionnaire in 3 of 10 patients, Carroll test scores ranging from 9 to 60 of 99, and monofilament testing with protective sensation achieved in 4 of 6 patients. Complications included rejection in nine recipients with Banff scores from II‐IV. One patient experienced graft failure 5 days after transplantation. Of the remaining patients, two were reported as receiving monotherapy and seven receiving dual or triple immunosuppression therapy. The inclusion of VCA in the OPTN Final Rule standardized parameters for safe implementation and data collection. The authors review the Organ Procurement and Transplantation Network database on upper extremity transplantation after the Final Rule in July 2014.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1600-6135
1600-6143
1600-6143
DOI:10.1111/ajt.15704